Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio: A Secondary Analysis of the RESCUE Clinical Trial.

Adamstein, Nicholas H; Cornel, Jan Hein; Davidson, Michael; Libby, Peter; de Remigis, Alessandra; Jensen, Camilla; Ekström, Kathrine; Ridker, Paul M

Adamstein, Nicholas H; Cornel, Jan Hein; Davidson, Michael; Libby, Peter; de Remigis, Alessandra; Jensen, Camilla; Ekström, Kathrine; Ridker, Paul M.

Afiliação

Adamstein NH; Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Cornel JH; Radboud University Medical Center, Nijmegen, the Netherlands.
Davidson M; Section of Cardiology, Department of Medicine, University of Chicago Medicine, Pritzker School of Medicine, Chicago, Illinois.
Libby P; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
de Remigis A; Novo Nordisk A/S, Søborg, Denmark.
Jensen C; Novo Nordisk A/S, Søborg, Denmark.
Ekström K; Novo Nordisk A/S, Søborg, Denmark.
Ridker PM; Center for Cardiovascular Disease Prevention, Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

JAMA Cardiol ; 8(2): 177-181, 2023 02 01.

Article em En | MEDLINE | ID: mdl-36449307

Assuntos

Aterosclerose; Interleucina-6; Adulto; Masculino; Humanos; Feminino; Idoso; Neutrófilos; Ligantes; Linfócitos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Aterosclerose Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google